Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia

Patients who undergo pediatric living donor liver transplantation (LDLT) sometimes develop graft fibrosis. Recently, Mac-2 binding protein glycosylation-modified isomer (M2BPGi) was developed as a new marker of hepatic fibrosis progression. We performed this study to examine the relationship between...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2024-03, Vol.56 (2), p.343-347
Main Authors: Ueno, Takehisa, Takase, Koki, Deguchi, Koichi, Nomura, Motonari, Watanabe, Miho, Kamiyama, Masafumi, Tazuke, Yuko, Kimura, Takeshi, Okuyama, Hiroomi
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients who undergo pediatric living donor liver transplantation (LDLT) sometimes develop graft fibrosis. Recently, Mac-2 binding protein glycosylation-modified isomer (M2BPGi) was developed as a new marker of hepatic fibrosis progression. We performed this study to examine the relationship between serum M2BPGi levels and liver histologic findings in patients after LDLT for biliary atresia. Patients aged
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2024.01.005